Comparable stake leader
TANG CAPITAL MANAGEMENT LLC
SEC ownership of Aurinia Pharmaceuticals Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001600620.
Disclosed value leader
TANG CAPITAL MANAGEMENT LLC
Comparable rows
50/50
Latest evidence
02 Jun 2026
- Public ticker
- AUPH on Nasdaq
- Parsed ownership sources
-
13D/G, 3/4/5, and 13F
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
TANG CAPITAL MANAGEMENT LLC
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
50 of 50
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
TANG CAPITAL MANAGEMENT LLC
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
02 Jun 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001600620
- Issuer location
- Edmonton, Alberta, Canada
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Aurinia Pharmaceuticals Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
TANG CAPITAL MANAGEMENT LLC
Disclosed value leader
TANG CAPITAL MANAGEMENT LLC
Comparable rows
50/50
Latest evidence
02 Jun 2026
13D/G
3/4/5
13F
Lead comparable stake: 10%
13D/G row: TANG CAPITAL MANAGEMENT LLC
Showing 1-8 of 50 holder rows.
Quick read
TANG CAPITAL MANAGEMENT LLC leads the comparable SEC ownership view at 10%.
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens TANG CAPITAL MANAGEMENT LLC's linked filing trail.
Comparable ownership
Top 5
TANG CAPITAL MANAGEMENT LLC
10%
ILJIN SNT Co., Ltd.
5%
ARMISTICE CAPITAL, LLC
4.5%
BlackRock, Inc.
6%
NEA Management Company, LLC
3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC |
13D/G
3/4/5
13F
10%+ Owner · Company
|
10%
|
$209,097,019
13,044,106 shares
|
+$13,058,134 | 02 Jun 2026 |
| ILJIN SNT Co., Ltd. |
13D/G
Chin Kyu Huh
|
5%
|
$57,509,241
6,535,141 shares
|
$0 | 11 Aug 2025 |
| ARMISTICE CAPITAL, LLC |
13D/G
|
4.5%
|
$51,840,000
6,400,000 shares
|
$0 | 31 Dec 2024 |
| BlackRock, Inc. |
13F
Company
|
6%
|
$116,270,621
7,845,521 shares
|
— | 31 Mar 2026 |
| NEA Management Company, LLC |
13F
Company
|
3%
|
$58,832,940
3,969,834 shares
|
— | 31 Mar 2026 |
| TWO SIGMA INVESTMENTS, LP |
13F
Company
|
2.6%
|
$50,813,408
3,428,705 shares
|
— | 31 Mar 2026 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
Company
|
2.5%
|
$48,674,334
3,284,368 shares
|
— | 31 Mar 2026 |
| STATE STREET CORP |
13F
Company
|
1.9%
|
$37,451,607
2,527,099 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to buying over the last 12 months. Net value: +$37,599,260.
Buys
$37,599,260
Insiders: 2
Sells
$0
Insiders: 0
Net
+$37,599,260
Shares: +2,529,212
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 2,529,212
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 1,629,212 | 0 | $24,910,454 | $0 | +$24,910,454 |
| 3-6 | 900,000 | 0 | $12,688,806 | $0 | +$12,688,806 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-20 of 29 reporting-owner rows connected to Aurinia Pharmaceuticals Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
29
Largest Forms 3/4/5 holder
Kevin Tang
Net 12M change
+$37,599,260
Latest report
04 Jun 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Kevin Tang | Chief Executive Officer, Director, 10%+ Owner | $199,313,939 | +$25,144,033 | +14% | Filing P/S | 29 May 2026 |
| TANG CAPITAL MANAGEMENT LLC | 10%+ Owner | $199,313,939 | +$12,455,227 | +6.7% | Filing P/S | 29 May 2026 |
| Peter Greenleaf | Chief Executive Officer, Director | $26,151,785 | Mixed | 27 Feb 2026 | ||
| Matthew Maxwell Donley | Chief Operating Officer | $9,667,048 | Mixed | 27 Feb 2026 | ||
| Stephen P. Robertson | Chief Legal Officer | $9,209,177 | Mixed | 18 May 2026 | ||
| Joseph M. Miller | Chief Financial Officer | $8,190,942 | Mixed | 27 Feb 2026 | ||
| Michael Robert Martin | Chief Business Officer | $2,918,164 | Mixed | 02 Mar 2023 | ||
| Scott Michael Habig | Chief Commercial Officer | $2,423,155 | Filing P/S | 06 Aug 2024 | ||
| Greg Keenan | SVP, Chief Medical Officer | $2,230,243 | Mixed | 06 Mar 2026 | ||
| Volker Knappertz | EVP, Research and Development | $1,946,681 | Filing P/S | 27 Feb 2024 | ||
| Michael S. Hearne | Chief Financial Officer | $1,721,254 | Mixed | 18 May 2026 | ||
| Ryan Cole | Chief Operating Officer | $1,721,254 | Mixed | 18 May 2026 | ||
| Neil Solomons | Chief Medical Officer | $1,024,131 | Mixed | 02 Mar 2022 | ||
| George M. Milne Jr. | Director | $886,534 | Mixed | 18 May 2023 | ||
| Robert Bindert Huizinga | EVP of Research | $781,208 | Mixed | 02 Mar 2022 | ||
| David R.w. Jayne | Director | $476,287 | Mixed | 21 Nov 2024 | ||
| Jeffrey A. Bailey | Director | $357,112 | Mixed | 04 Jun 2026 | ||
| Craig A. Johnson | Director | $228,802 | Mixed | 04 Jun 2026 | ||
| Jill Leversage | Director | $211,197 | Mixed | 21 Nov 2024 | ||
| Karen L. Smith | Director | $209,123 | Mixed | 21 Nov 2024 |
Recent insider transactions for Aurinia Pharmaceuticals Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Craig A. Johnson | AUPH | Director Stock Option (right to buy) | Award | 23,931 | 23,931 | 04 Jun 2026 | Direct | |||
| Kathleen Goetz | AUPH | Director Stock Option (right to buy) | Award | 23,931 | 23,931 | 04 Jun 2026 | Direct | |||
| Tina Susan Nova | AUPH | Director Stock Option (right to buy) | Award | 23,931 | 23,931 | 04 Jun 2026 | Direct | |||
| Jeffrey A. Bailey | AUPH | Director Stock Option (right to buy) | Award | 23,931 | 23,931 | 04 Jun 2026 | Direct | |||
| Tang Kevin | AUPH | Common Shares | Purchase | 1.6% | $3,147,756 | $15.28 | 206,005 | 13,044,106 | 02 Jun 2026 | By LP |
| Kevin Tang | AUPH | Common Shares | Purchase | 1.6% | $3,147,756 | $15.28 | 206,005 | 13,044,106 | 02 Jun 2026 | By LP |
| Tang Kevin | AUPH | Short Put Options (potential obligation to buy) | Other | 10,000 | 10,000 | 02 Jun 2026 | By LP | |||
| Kevin Tang | AUPH | Short Put Options (potential obligation to buy) | Other | 10,000 | 10,000 | 02 Jun 2026 | By LP | |||
| Tang Kevin | AUPH | Common Shares | Purchase | 2.75% | $5,250,520 | $15.28 | 343,620 | 12,838,101 | 01 Jun 2026 | By LP |
| Kevin Tang | AUPH | Common Shares | Purchase | 2.75% | $5,250,520 | $15.28 | 343,620 | 12,838,101 | 01 Jun 2026 | By LP |
| Tang Kevin | AUPH | Common Shares | Purchase | 2.17% | $4,056,951 | $15.31 | 264,981 | 12,494,481 | 29 May 2026 | By LP |
| Kevin Tang | AUPH | Common Shares | Purchase | 2.17% | $4,056,951 | $15.31 | 264,981 | 12,494,481 | 29 May 2026 | By LP |
| Stephen P. Robertson | AUPH | Common Stock | Award | 22.8% | 115,541 | 621,402 | 18 May 2026 | Direct | ||
| Michael S. Hearne | AUPH | Common Stock | Award | 116,144 | 116,144 | 18 May 2026 | Direct | |||
| Michael S. Hearne | AUPH | Employee Stock Option (right to buy) | Award | 70,230 | 70,230 | 18 May 2026 | Direct | |||
| Ryan Cole | AUPH | Common Stock | Award | 116,144 | 116,144 | 18 May 2026 | Direct | |||
| Ryan Cole | AUPH | Employee Stock Option (right to buy) | Award | 70,230 | 70,230 | 18 May 2026 | Direct | |||
| Greg Keenan | AUPH | Common Stock | Tax liability | -4.96% | -8,069 | 154,449 | 06 Mar 2026 | Direct | ||
| Kevin Tang | AUPH | Common Shares | Purchase | 1.53% | $2,619,438 | $14.22 | 184,208 | 12,229,500 | 03 Mar 2026 | By LP |
| Kevin Tang | AUPH | Common Shares | Purchase | 1.68% | $2,842,833 | $14.26 | 199,353 | 12,045,292 | 02 Mar 2026 | By LP |
| Joseph M. Miller | AUPH | Common Stock | Tax liability | -6.11% | -37,511 | 576,421 | 02 Mar 2026 | Direct | ||
| Matthew Maxwell Donley | AUPH | Common Stock | Tax liability | -5.65% | -40,761 | 680,299 | 02 Mar 2026 | Direct | ||
| Peter S. Greenleaf | AUPH | Common Stock | Tax liability | -5.2% | -100,890 | 1,840,379 | 02 Mar 2026 | Direct | ||
| Stephen P. Robertson | AUPH | Common Stock | Tax liability | -6.73% | -36,525 | 505,861 | 02 Mar 2026 | Direct | ||
| Kevin Tang | AUPH | Common Shares | Purchase | 4.56% | $7,226,535 | $13.99 | 516,439 | 11,845,939 | 27 Feb 2026 | By LP |
| Joseph M. Miller | AUPH | Common Stock | Award | 10.3% | 57,229 | 613,932 | 27 Feb 2026 | Direct | ||
| Joseph M. Miller | AUPH | Employee Stock Option (right to buy) | Award | 95,700 | 95,700 | 27 Feb 2026 | Direct | |||
| Matthew Maxwell Donley | AUPH | Common Stock | Award | 8.77% | 58,160 | 721,060 | 27 Feb 2026 | Direct | ||
| Matthew Maxwell Donley | AUPH | Employee Stock Option (right to buy) | Award | 97,256 | 97,256 | 27 Feb 2026 | Direct | |||
| Peter S. Greenleaf | AUPH | Common Stock | Award | 11.3% | 196,403 | 1,941,269 | 27 Feb 2026 | Direct | ||
| Peter S. Greenleaf | AUPH | Employee Stock Option (right to buy) | Award | 328,424 | 328,424 | 27 Feb 2026 | Direct | |||
| Greg Keenan | AUPH | Common Stock | Award | 33.3% | 40,586 | 162,518 | 27 Feb 2026 | Direct | ||
| Greg Keenan | AUPH | Employee Stock Option (right to buy) | Award | 67,870 | 67,870 | 27 Feb 2026 | Direct | |||
| Stephen P. Robertson | AUPH | Common Stock | Award | 12.2% | 59,090 | 542,386 | 27 Feb 2026 | Direct | ||
| Stephen P. Robertson | AUPH | Employee Stock Option (right to buy) | Award | 98,813 | 98,813 | 27 Feb 2026 | Direct | |||
| Matthew Maxwell Donley | AUPH | Common Stock | Tax liability | -4.73% | -32,901 | 662,900 | 20 Feb 2026 | Direct | ||
| Peter S. Greenleaf | AUPH | Common Stock | Tax liability | -5.43% | -100,171 | 1,744,866 | 20 Feb 2026 | Direct | ||
| Joseph M. Miller | AUPH | Common Stock | Tax liability | -5.5% | -32,424 | 556,703 | 20 Feb 2026 | Direct | ||
| Stephen P. Robertson | AUPH | Common Stock | Tax liability | -6.69% | -34,638 | 483,296 | 20 Feb 2026 | Direct | ||
| Greg Keenan | AUPH | Common Stock | Tax liability | -8.65% | -11,552 | 121,932 | 02 Feb 2026 | Direct | ||
| Stephen P. Robertson | AUPH | Common Stock | Tax liability | -7.23% | -40,385 | 517,934 | 02 Jan 2026 | Direct | ||
| Stephen P. Robertson | AUPH | Common Stock | Award | 9.54% | 48,558 | 557,434 | 02 Jan 2026 | Direct | ||
| Matthew Maxwell Donley | AUPH | Common Stock | Tax liability | -5.79% | -42,787 | 695,801 | 02 Jan 2026 | Direct | ||
| Matthew Maxwell Donley | AUPH | Common Stock | Award | 7.96% | 54,166 | 734,631 | 02 Jan 2026 | Direct | ||
| Joseph M. Miller | AUPH | Common Stock | Tax liability | -6.38% | -40,161 | 589,127 | 02 Jan 2026 | Direct | ||
| Joseph M. Miller | AUPH | Common Stock | Award | 8.49% | 49,038 | 626,399 | 02 Jan 2026 | Direct | ||
| Peter S. Greenleaf | AUPH | Common Stock | Tax liability | -5.78% | -113,169 | 1,845,037 | 02 Jan 2026 | Direct | ||
| Peter S. Greenleaf | AUPH | Common Stock | Award | 9.24% | 165,384 | 1,954,329 | 02 Jan 2026 | Direct | ||
| Jeffrey A. Bailey | AUPH | Common Shares | Tax liability | -10.6% | -2,716 | 22,775 | 21 Nov 2025 | Direct | ||
| Craig A. Johnson | AUPH | Common Shares | Tax liability | -29.3% | -6,039 | 14,592 | 21 Nov 2025 | Direct |
* marks a reported price that did not pass the local price check.